Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Limbica
- Development stage
- Unknown
- Lead developer
- Bio-STILOGIT Pharmaceuticals
- Administration
- Oral
01
Overview
Limbica is a dietary supplement developed and marketed by Bio-STILOGIT Pharmaceuticals, primarily in the Italian market. It is formulated to support psychological well-being and the normal functioning of the nervous system. The product typically contains a combination of **L-tryptophan**, an essential amino acid that acts as a biochemical precursor to the neurotransmitter serotonin, along with **magnesium**, **niacin (Vitamin B3)**, and **vitamin B6**. These ingredients work synergistically to aid in mood regulation, support cognitive function, and reduce tiredness and fatigue. It is sold as a consumer retail product rather than a prescription pharmaceutical.
- Brand names
- Limbica
Beyond the preview
Go deeper on Limbica.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Limbica.